Vast Renewables [VSTE] - Last Close: $3.09
Australian solar power firm Vast Renewables is surging despite no obvious company-specific news to explain the move.
Vast Renewables rallied 33.7% on Friday after publishing “limited” operational & financial results for the first half of its fiscal 2024 before the open.
However, the results weren’t great. Vast’s revenues increased, but it still reported massive operating loss of $(66.44) per share.
Whatever the reason, VSTE is skyrocketing. It’s up 235.9% on nearly 2 million shares traded.
My Take: I am not sure why VSTE is rallying so sharply this morning, but I suspect we could see a pullback in the near future due to the lack of obvious substance behind this move.
Doma Holdings [DOMA] - Last Close: $4.54
Late Thursday, Doma said it entered into an agreement with Title Resource Group to go private in an all-cash deal.
Shareholders will receive $6.29 per share under the terms of the deal, equaling a 43% premium over DOMA’s Friday closing price on Wednesday.
DOMA is up 34.7% on in today’s premarket, but volume is light at only 50K shares traded.
My Take: DOMA is still a few points shy of its buyout bid, so there could be more upside here. However, it’s minor, so it might not be worth the risk .
Galera Therapeutics [GRTX] - Last Close: $0.14
An earnings beat is lifting shares of this tiny biotech stock in today’s premarket.
On Thursday morning, Galera reported a thinner-than-expected loss of $(0.10) per share, easily eclipsing the consensus estimate of $(0.35) per share.
GRTX is up 42.9% on over 8 million shares traded.
My Take: GRTX is coming off of a BIG pullback, so that might explain why this move was so sharp. It was trading for $0.25 per share prior to the pullback, and it could face resistance at that same mark on the way up.
Sunshine Biopharma [SBFM] - Last Close: $0.0605
This micro-float biotech is surging after publishing its Form 10-K in Thursday’s aftermarket.
The reported included various updates on the company’s business operations, drug pipeline, intellectual property, and more.
After skimming the 10-K, nothing stands out as a potential catalyst for today’s rally, but the report is the most likely trigger for the move.
SBFM is up 109.5% on over 40 million shares traded.
My Take: The reason for SBFM’s sudden rally is likely buried somewhere in the 10-K. Share prices were up to above $0.20 per share in early February, so there could be upside potential here.